-
EP4054606
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4054606
| EP4054606 - USE OF MBV FOR TREATING AUTOIMMUNE DISEAE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.08.2022 Database last updated on 13.07.2024 | |
| Former | The international publication has been made Status updated on 01.05.2021 | Most recent event Tooltip | 17.05.2024 | Amendment by applicant | Applicant(s) | For all designated states University of Pittsburgh - of the Commonwealth System of Higher Education 1st Floor Gardner Steel Conference Center 130 Thackeray Avenue Pittsburgh, Pennsylvania 15260 / US | [2022/37] | Inventor(s) | 01 /
BADYLAK, Stephen c/o University of Pittsburgh 130 Thackeray Ave. 1st Floor GSCC Pittsburgh, Pennsylvania 15260 / US | 02 /
HUSSEY, George S. c/o University of Pittsburgh 130 Thackeray Ave. 1st Floor GSCC Pittsburgh, Pennsylvania 15260 / US | 03 /
CRUM, Raphael c/o University of Pittsburgh 130 Thackeray Ave. 1st Floor GSCC Pittsburgh, Pennsylvania 15260 / US | [2022/37] | Representative(s) | Tombling, Adrian George Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [2022/37] | Application number, filing date | 20879111.1 | 22.10.2020 | [2022/37] | WO2020US56899 | Priority number, date | US201962925129P | 23.10.2019 Original published format: US 201962925129 P | [2022/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021081231 | Date: | 29.04.2021 | Language: | EN | [2021/17] | Type: | A1 Application with search report | No.: | EP4054606 | Date: | 14.09.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.04.2021 takes the place of the publication of the European patent application. | [2022/37] | Search report(s) | International search report - published on: | AU | 29.04.2021 | (Supplementary) European search report - dispatched on: | EP | 30.10.2023 | Classification | IPC: | A61K35/35, A61P37/02, A61K35/12, A61K31/7105, A61K35/28, A61K35/51 | [2023/48] | CPC: |
A61P17/06 (EP,AU,KR,US);
A61K9/51 (AU);
A61K35/28 (EP,KR);
A61K35/22 (US);
A61K31/7105 (EP,KR);
A61K35/12 (AU);
A61K35/38 (US);
A61K35/51 (EP,KR);
A61K9/127 (US);
A61P1/04 (KR);
A61P19/02 (EP,AU,KR,US);
A61P29/00 (US);
|
| Former IPC [2022/37] | A61K35/35, A61P37/02, A61K35/12 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/37] | Title | German: | VERWENDUNG VON MBV ZUR BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN | [2022/37] | English: | USE OF MBV FOR TREATING AUTOIMMUNE DISEAE | [2022/37] | French: | UTILISATION DES VÉSICULES LIÉES À LA MATRICE POUR LE TRAITEMENT D'UNE MALADIE AUTO-IMMUNE | [2022/37] | Entry into regional phase | 13.05.2022 | National basic fee paid | 13.05.2022 | Search fee paid | 13.05.2022 | Designation fee(s) paid | 13.05.2022 | Examination fee paid | Examination procedure | 13.05.2022 | Examination requested [2022/37] | 16.05.2024 | Amendment by applicant (claims and/or description) | 16.05.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 15.09.2022 | Renewal fee patent year 03 | 13.09.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2017151862 (UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION [US]); | [X]WO2018204848 (UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION [US]); | [PX]WO2019213482 (UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION [US]); |